Design Therapeutics, Inc.

DSGN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$22,563$21,200$26,500$298,569
Short-Term Investments$222,914$260,598$303,887$85,495
Receivables$1,263$1,432$1,115$110
Inventory$0$0$0$0
Other Curr. Assets$1,300$1,354$3,617$1,261
Total Curr. Assets$248,040$284,584$335,119$385,435
Property Plant & Equip (Net)$3,626$4,629$5,559$5,122
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$427$430$459$0
Total NC Assets$4,053$5,059$6,018$5,122
Other Assets$0$0$0$0
Total Assets$252,093$289,643$341,137$390,557
Liabilities
Payables$2,186$1,940$3,025$1,620
Short-Term Debt$800$716$640$489
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,476$6,966$7,111$3,174
Total Curr. Liab.$8,462$9,622$10,776$5,283
LT Debt$1,534$2,334$3,051$3,144
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$1,534$2,334$3,051$3,144
Other Liabilities$0$0$0$0
Cap. Leases$2,334$3,050$3,691$3,633
Total Liabilities$9,996$11,956$13,827$8,427
Equity
Pref Stock$0$0$0$0
Common Stock$6$6$6$6
Retained Earnings-$227,214-$177,626-$110,764-$47,456
AOCI$475$62-$3,356-$244
Other Equity$468,830$455,245$441,424$429,824
Total Equity$242,097$277,687$327,310$382,130
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$252,093$289,643$341,137$390,557
Net Debt-$20,229-$18,150-$22,809-$294,936
Design Therapeutics, Inc. (DSGN) Financial Statements & Key Stats | AlphaPilot